Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LINC00862 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SLC22A25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TRIP12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KDM5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
EFCAB10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYO1E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAMTS9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IKZF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIK3AP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NSUN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCUN1D1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNFRSF17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C4orf32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC44A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZXDB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RDH10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL6R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on